WEKO3
アイテム
{"_buckets": {"deposit": "e073634f-0e08-4cfc-83db-d10d44380232"}, "_deposit": {"id": "14959", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "14959"}, "status": "published"}, "_oai": {"id": "oai:niigata-u.repo.nii.ac.jp:00014959", "sets": ["456", "1076"]}, "item_7_alternative_title_1": {"attribute_name": "その他のタイトル", "attribute_value_mlt": [{"subitem_alternative_title": "Etiology, Prevention and Treatment of Postmenopausal osteoporosis"}]}, "item_7_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2001-04", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "4", "bibliographicPageEnd": "126", "bibliographicPageStart": "122", "bibliographicVolumeNumber": "115", "bibliographic_titles": [{"bibliographic_title": "新潟医学会雑誌"}, {"bibliographic_title": "新潟医学会雑誌", "bibliographic_titleLang": "en"}]}]}, "item_7_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "The etiology of postmenopausal osteoporosis has not completely been solved. Recent studies showed hypoestrogenic state caused the activation of cytokines (IL-1, IL-6, TNF-_α, GM-CSF etc. ) from monocyte, stromal cells and osteoblast in bone marrow, and activated bone resorption and suppressed bone formation. Hormone replacement therapy (HRT) is the first choice of the treatment for postmenopausal osteoporosis. HRT is effective for not only osteoporosis but also climacteric disturbance and hyperlipidemia. HRT causes the increase of bone mineral density within 2 years, and mainteins it after 2 years. Vitamin D receptor gene polymorphism (Taq) is useful to detect the effect of HRT for osteoporosis. It is important for us to detect the high risk women for osteoporosis. Ovarian dysfunction, castration and GnRH agonist therapy etc. are risk factors for osteoporosis. Pregnancy and lactation may not be risk factors. There are two factors, i.e. genetic factor and environmental factor, to cause osteoporosis. The evaluation of genetic factor and the improvement of life style are very important to prevent osteoporosis.", "subitem_description_type": "Abstract"}]}, "item_7_full_name_3": {"attribute_name": "著者別名", "attribute_value_mlt": [{"nameIdentifiers": [{"nameIdentifier": "96348", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Kurabayashi, Takumi"}]}]}, "item_7_publisher_7": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "新潟医学会"}]}, "item_7_select_19": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_select_item": "publisher"}]}, "item_7_source_id_11": {"attribute_name": "書誌レコードID", "attribute_value_mlt": [{"subitem_source_identifier": "AN00182415", "subitem_source_identifier_type": "NCID"}]}, "item_7_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "00290440", "subitem_source_identifier_type": "ISSN"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "倉林, 工"}], "nameIdentifiers": [{"nameIdentifier": "96347", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2019-08-07"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "115(4)_122-126.pdf", "filesize": [{"value": "1.1 MB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 1100000.0, "url": {"label": "115(4)_122-126.pdf", "url": "https://niigata-u.repo.nii.ac.jp/record/14959/files/115(4)_122-126.pdf"}, "version_id": "156172db-bd44-4889-8195-90464cbb7b9e"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "postmenopausal osteoporosis", "subitem_subject_scheme": "Other"}, {"subitem_subject": "hormone replacement therapy", "subitem_subject_scheme": "Other"}, {"subitem_subject": "estrogen", "subitem_subject_scheme": "Other"}, {"subitem_subject": "cytokines", "subitem_subject_scheme": "Other"}, {"subitem_subject": "gene polymorphism", "subitem_subject_scheme": "Other"}, {"subitem_subject": "閉経後骨粗鬆症症", "subitem_subject_scheme": "Other"}, {"subitem_subject": "ホルモン補充療法", "subitem_subject_scheme": "Other"}, {"subitem_subject": "エストロゲン", "subitem_subject_scheme": "Other"}, {"subitem_subject": "サイトカイン", "subitem_subject_scheme": "Other"}, {"subitem_subject": "遺伝子多型", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "departmental bulletin paper", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "3) 閉経後骨粗鬆症の病態・予防・治療(シンポジウム 骨粗鬆症の病態と治療, 第554回新潟医学会)", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "3) 閉経後骨粗鬆症の病態・予防・治療(シンポジウム 骨粗鬆症の病態と治療, 第554回新潟医学会)"}, {"subitem_title": "3) 閉経後骨粗鬆症の病態・予防・治療(シンポジウム 骨粗鬆症の病態と治療, 第554回新潟医学会)", "subitem_title_language": "en"}]}, "item_type_id": "7", "owner": "1", "path": ["456", "1076"], "permalink_uri": "http://hdl.handle.net/10191/48114", "pubdate": {"attribute_name": "公開日", "attribute_value": "2017-11-07"}, "publish_date": "2017-11-07", "publish_status": "0", "recid": "14959", "relation": {}, "relation_version_is_last": true, "title": ["3) 閉経後骨粗鬆症の病態・予防・治療(シンポジウム 骨粗鬆症の病態と治療, 第554回新潟医学会)"], "weko_shared_id": null}
3) 閉経後骨粗鬆症の病態・予防・治療(シンポジウム 骨粗鬆症の病態と治療, 第554回新潟医学会)
http://hdl.handle.net/10191/48114
http://hdl.handle.net/10191/48114ed9af2c3-a589-44a7-9b1c-483eed226808
名前 / ファイル | ライセンス | アクション |
---|---|---|
![]() |
|
Item type | 紀要論文 / Departmental Bulletin Paper(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2017-11-07 | |||||
タイトル | ||||||
タイトル | 3) 閉経後骨粗鬆症の病態・予防・治療(シンポジウム 骨粗鬆症の病態と治療, 第554回新潟医学会) | |||||
タイトル | ||||||
言語 | en | |||||
タイトル | 3) 閉経後骨粗鬆症の病態・予防・治療(シンポジウム 骨粗鬆症の病態と治療, 第554回新潟医学会) | |||||
言語 | ||||||
言語 | jpn | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | postmenopausal osteoporosis | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | hormone replacement therapy | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | estrogen | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | cytokines | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | gene polymorphism | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | 閉経後骨粗鬆症症 | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | ホルモン補充療法 | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | エストロゲン | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | サイトカイン | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | 遺伝子多型 | |||||
資源タイプ | ||||||
資源 | http://purl.org/coar/resource_type/c_6501 | |||||
タイプ | departmental bulletin paper | |||||
その他のタイトル | ||||||
その他のタイトル | Etiology, Prevention and Treatment of Postmenopausal osteoporosis | |||||
著者 |
倉林, 工
× 倉林, 工 |
|||||
著者別名 | ||||||
識別子 | 96348 | |||||
識別子Scheme | WEKO | |||||
姓名 | Kurabayashi, Takumi | |||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | The etiology of postmenopausal osteoporosis has not completely been solved. Recent studies showed hypoestrogenic state caused the activation of cytokines (IL-1, IL-6, TNF-_α, GM-CSF etc. ) from monocyte, stromal cells and osteoblast in bone marrow, and activated bone resorption and suppressed bone formation. Hormone replacement therapy (HRT) is the first choice of the treatment for postmenopausal osteoporosis. HRT is effective for not only osteoporosis but also climacteric disturbance and hyperlipidemia. HRT causes the increase of bone mineral density within 2 years, and mainteins it after 2 years. Vitamin D receptor gene polymorphism (Taq) is useful to detect the effect of HRT for osteoporosis. It is important for us to detect the high risk women for osteoporosis. Ovarian dysfunction, castration and GnRH agonist therapy etc. are risk factors for osteoporosis. Pregnancy and lactation may not be risk factors. There are two factors, i.e. genetic factor and environmental factor, to cause osteoporosis. The evaluation of genetic factor and the improvement of life style are very important to prevent osteoporosis. | |||||
書誌情報 |
新潟医学会雑誌 en : 新潟医学会雑誌 巻 115, 号 4, p. 122-126, 発行日 2001-04 |
|||||
出版者 | ||||||
出版者 | 新潟医学会 | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 00290440 | |||||
書誌レコードID | ||||||
収録物識別子タイプ | NCID | |||||
収録物識別子 | AN00182415 | |||||
著者版フラグ | ||||||
値 | publisher |